TRACON Pharmaceuticals Inc
General ticker "TCON" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $94.6K
TRACON Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -30.7%.
Estimated limits based on current volatility of 2.5%: low 0.03$, high 0.03$
Factors to consider:
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.93$, 5.66$]
- 2024-12-30 to 2025-12-30 estimated range: [2.97$, 7.00$]
Financial Metrics affecting the TCON estimates:
- Negative: Non-GAAP EPS, $ of 0.07 <= 0.10
- Negative: Operating profit margin, % of -43.50 <= 1.03
- Positive: Operating cash flow per share per price, % of 59.69 > 12.76
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Interest expense per share, $ of 4.48 > 0.74
Short-term TCON quotes
Long-term TCON plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.35MM | $0.00MM | $12.04MM |
| Operating Expenses | $28.69MM | $27.89MM | $21.32MM |
| Operating Income | $-28.35MM | $-27.89MM | $-9.27MM |
| Non-Operating Income | $-0.32MM | $-1.24MM | $5.68MM |
| Interest Expense | $0.32MM | $0.99MM | $7.30MM |
| R&D Expense | $11.15MM | $13.89MM | $12.28MM |
| Income(Loss) | $-28.67MM | $-29.14MM | $-3.59MM |
| Profit(Loss) | $-28.67MM | $-29.14MM | $-3.59MM |
| Stockholders Equity | $11.71MM | $-7.15MM | $-0.81MM |
| Assets | $26.56MM | $19.47MM | $10.11MM |
| Operating Cash Flow | $-22.57MM | $-26.24MM | $3.68MM |
| Capital expenditure | $0.05MM | $0.02MM | $0.00MM |
| Investing Cash Flow | $3.95MM | $-0.02MM | $0.00MM |
| Financing Cash Flow | $10.56MM | $19.68MM | $-12.54MM |
| Earnings Per Share* | $-33.30 | $-28.02 | $-2.20 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.